IIT-B researcher gets DCGI gesture to launch algo-based COVID-19 testing instrument Kumar Jeetendra | June 22, 2021 Bengaluru-based tech startup Algorithmic Biologics has received regulatory approvals to launch its COVID-19 testing method that can help scale up testing for the deadly virus infection at half the prevailing cost and one-tenth of the time. Called Tapestry, the new testing tool is developed by the startup launched by IIT-Bombay professor Manoj Gopalkrishnan. It enables …
Elisa Antigen Test to Fast-pace India’s testing, monitoring, and Covid-19 management efforts Kumar Jeetendra | June 22, 2021 New Delhi; 22nd June 2021: India’s biotechnology leader in the IVD space, J Mitra and Company has launched the Covid-19 Ag Microlisa Elisa Test kit (Elisa Antigen Test) for the Indian market. The test kit will provide an impetus to India’s fight against Covid-19 by significantly bringing down the overall cost of testing. It will …
Ladies treated with fertility drugs don’t have expanded breast cancer risk, study shows Kumar Jeetendra | June 21, 2021 Drugs frequently used during fertility treatments to release eggs don’t increase the chance of developing breast cancer, new research has shown. Researchers from King’s College London, in partnership with King’s Fertility, analyzed studies between 1.8 million women undergoing fertility treatments. These women were followed up in studies for a normal period of 27 years and …
Sputnik V COVID-19 vaccine carry out postponed in Delhi Kumar Jeetendra | June 20, 2021 The roll out of Russian COVID-19 vaccine Sputnik V at Indraprastha Apollo and Madhukar Rainbow Children’s Hospital in Delhi has been delayed for some days, officials said on Sunday. A spokesperson of Apollo Hospitals said the facility in Delhi will tentatively start administering the two-dose vaccine by June 25. An official had earlier said the …
Delta variant establishes more than 6% of tested COVID-19 cases with virus variant in NYC: Health division Kumar Jeetendra | June 19, 2021 The Delta variant, first detected in India, constituted over 6 per cent of COVID-19 cases tested for virus variants in New York City, according to official data from the city’s health department. The New York City Health Department said in its recent update that out of the 105 NYC COVID-19 cases tested for variant viruses …
New programming created to help recognize patients requiring ventilator support: Govt Kumar Jeetendra | June 19, 2021 The government on Saturday said that a new software — Covid Severity Score — has been developed to identify patients who require ventilator support as well as detect emergency and intensive care unit needs early. The software consists of an algorithm that measures a set of parameters, and then identifies patients likely to require ventilator …
AstraZeneca vaccine’s investigator backs India’s 12–16-week Covishield dose gap Kumar Jeetendra | June 19, 2021 Backing the 12-16 weeks gap between the two doses of Covishield in India, the chief investigator of the AstraZeneca vaccine clinical trials on June 18 said that the level of protection provided by one dose of the preventive significantly increases in the second and third months after the jab. In an interview with The Wire, …
UK opens up COVID-19 vaccines to all adults in final push’ for protection Kumar Jeetendra | June 18, 2021 The UK’s health officials on Friday opened up the country’s COVID-19 vaccination programme to all adults, in what has been dubbed as the “final push” to offer protection against the deadly virus. The National Health Service (NHS) said everyone aged 18 and over is being urged to arrange a jab if they have not had …
Perlara partners with Vivan Therapeutics to tackle rare genetic diseases Kumar Jeetendra | June 17, 2021 Berkeley, California, London, United Kingdom – June 17, 2021 – – Perlara PBC, a rare disease public benefit company today announced a rare genetic diseases collaboration with Vivan Therapeutics to identify novel therapeutics for rare genetic diseases. Under this agreement, Perlara will refer highly motivated patients, families and foundations seeking to embark on a discovery …
Which COVID vaccine is ideal? Here’s the reason that is truly difficult to reply Kumar Jeetendra | June 17, 2021 With the rollout of COVID-19 vaccines accelerating, people are increasingly asking which vaccine is best? Even if we tried to answer this question, defining which vaccine is “best” is not simple. Does that mean the vaccine better at protecting you from serious disease? The one that protects you from whichever variant is circulating near you? …
Weight-based dosing procedure may influence immunotherapy results, shows study Kumar Jeetendra | June 15, 2021 Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center. The findings, published in the Journal for ImmunoTherapy of Cancer, run counter to current practice trends, which favor fixed dosing, in which …
WHO chief Tedros Adhanom Ghebreyesus says vaccine need surpasses G7 vows Kumar Jeetendra | June 13, 2021 The head of the World Health Organisation has welcomed the vaccine-sharing announcements coming out of the Group of Seven summit but says “we need more, and we need them faster.” “The challenge, I said to the G-7 leaders, was that to truly end the pandemic, our goal must be to vaccinate at least 70% of …
